Bristol Myers Squibb have extended their research collaboration aimed at designing and optimizing small-molecule drugs for ...

Diabetes was tied to a 3.3 times greater risk of earlier loss of walking ability in a study of amyotrophic lateral sclerosis ...

EKZ-102, an experimental oral therapy for amyotrophic lateral sclerosis (ALS), is on track to enter early clinical testing in ...

Once in a while, there’s a topic on the ALS News Today Forums that inspires a new column. The question posted was a simple one: “Do you celebrate ALS-related anniversaries?” I intended my reply to be ...